300760 迈瑞医疗
已收盘 04-09 15:00:00
资讯
新帖
简况
迈瑞医疗,正在“换挡”
格隆汇 · 04-08 18:39
迈瑞医疗,正在“换挡”
迈瑞医疗(300760)披露控股股东部分股份质押公告,4月7日股价下跌0.4%
证券之星 · 04-07 17:13
迈瑞医疗(300760)披露控股股东部分股份质押公告,4月7日股价下跌0.4%
近300家公司获机构密集调研,迈瑞医疗最受关注
证券之星 · 04-07 16:27
近300家公司获机构密集调研,迈瑞医疗最受关注
迈瑞医疗:4月2日高管李朝阳、赵云增持股份合计1.5万股
证券之星 · 04-03
迈瑞医疗:4月2日高管李朝阳、赵云增持股份合计1.5万股
迈瑞医疗:数智化方案为客户带来全方位的临床和管理价值
证券之星 · 04-02
迈瑞医疗:数智化方案为客户带来全方位的临床和管理价值
迈瑞医疗:3月31日郭艳美、李朝阳增持股份合计2.47万股
证券之星 · 04-01
迈瑞医疗:3月31日郭艳美、李朝阳增持股份合计2.47万股
迈瑞医疗:公司H股上市事项目前正在监管审核中
证券之星 · 04-01
迈瑞医疗:公司H股上市事项目前正在监管审核中
迈瑞医疗:2025年净利润率下降了6.57个百分点
证券之星 · 04-01
迈瑞医疗:2025年净利润率下降了6.57个百分点
中银证券:给予迈瑞医疗买入评级
证券之星 · 04-01
中银证券:给予迈瑞医疗买入评级
迈瑞医疗2025年营收同比下降9.4%,净利润降30.3%,新兴业务增长30% | 财报见闻
华尔街见闻 · 03-30
迈瑞医疗2025年营收同比下降9.4%,净利润降30.3%,新兴业务增长30% | 财报见闻
迈瑞医疗2025年营收332.82亿,国际业务占比提升至53%,研发投入39.29亿,公司累计专利数量超12000件
新浪证券 · 03-30
迈瑞医疗2025年营收332.82亿,国际业务占比提升至53%,研发投入39.29亿,公司累计专利数量超12000件
股市必读:迈瑞医疗(300760)3月27日董秘有最新回复
证券之星 · 03-30
股市必读:迈瑞医疗(300760)3月27日董秘有最新回复
迈瑞医疗:国内业务2026年全年有望实现正增长
证券之星 · 03-28
迈瑞医疗:国内业务2026年全年有望实现正增长
迈瑞医疗:基于可穿戴传感器以及AI诊断和预警算法的慢病管理新方案
证券之星 · 03-25
迈瑞医疗:基于可穿戴传感器以及AI诊断和预警算法的慢病管理新方案
迈瑞医疗:IVD核心业务国内市场占有率三年内从10%提升至20%
证券之星 · 03-24
迈瑞医疗:IVD核心业务国内市场占有率三年内从10%提升至20%
迈瑞医疗:与美国Teratech的专利诉讼仍处于早期阶段
证券之星 · 03-24
迈瑞医疗:与美国Teratech的专利诉讼仍处于早期阶段
迈瑞医疗:高管在年报披露前15日内不得买卖本公司股票
证券之星 · 03-24
迈瑞医疗:高管在年报披露前15日内不得买卖本公司股票
迈瑞医疗:预计国内业务2026年全年有望实现正增长
证券之星 · 03-24
迈瑞医疗:预计国内业务2026年全年有望实现正增长
迈瑞医疗:2025年前三季度MT 8000全实验室智能化流水线销售超过20套
证券之星 · 03-24
迈瑞医疗:2025年前三季度MT 8000全实验室智能化流水线销售超过20套
迈瑞医疗:微创外科、心血管是公司定义的高潜力业务
证券之星 · 03-20
迈瑞医疗:微创外科、心血管是公司定义的高潜力业务
加载更多
公司概况
公司名称:
深圳迈瑞生物医疗电子股份有限公司
所属行业:
专用设备制造业
上市日期:
2018-10-16
主营业务:
深圳迈瑞生物医疗电子股份有限公司的主营业务是医疗器械的研发、制造、营销及服务。公司的主要产品是体外诊断类产品、生命信息与支持类产品、医学影像类产品、新兴业务类产品、其他业务。2025年,公司自主研发的发明专利“试剂、分析血小板的方法及血液细胞分析仪”荣获第十届广东专利奖金奖。
发行价格:
48.80
{"stockData":{"symbol":"300760","market":"SZ","secType":"STK","nameCN":"迈瑞医疗","latestPrice":156.3,"timestamp":1775718186000,"preClose":162.92,"halted":0,"volume":11893884,"delay":0,"changeRate":-0.0406,"floatShares":1211000000,"shares":1212000000,"eps":3.7966,"marketStatus":"已收盘","change":-6.62,"latestTime":"04-09 15:00:00","open":161.5,"high":161.91,"low":156.18,"amount":1880000000,"amplitude":0.0352,"askPrice":156.34,"askSize":20,"bidPrice":156.3,"bidSize":272,"shortable":0,"etf":0,"ttmEps":3.7966,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1775784600000},"marketStatusCode":5,"adr":0,"adjPreClose":162.92,"symbolType":"stock","openAndCloseTimeList":[[1775698200000,1775705400000],[1775710800000,1775718000000]],"highLimit":179.21,"lowLimit":146.63,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":1212441394,"isCdr":false,"pbRate":5.19,"roa":"--","peRate":41.168414,"roe":"21.58%","epsLYR":6.7147,"committee":0.717439,"marketValue":189505000000,"turnoverRate":0.0098,"status":1,"floatMarketCap":189342000000},"requestUrl":"/m/hq/s/300760","defaultTab":"news","newsList":[{"id":"2625551948","title":"迈瑞医疗,正在“换挡”","url":"https://stock-news.laohu8.com/highlight/detail?id=2625551948","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625551948?lang=zh_cn&edition=full","pubTime":"2026-04-08 18:39","pubTimestamp":1775644764,"startTime":"0","endTime":"0","summary":"拐点已现","market":"hk","thumbnail":"https://img3.gelonghui.com/cd535-be23de1c-b81f-4bd4-8c83-8a3f36dd9cc7.jpg?guru_height=665&guru_width=1280&guru_size=123726","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/cd535-be23de1c-b81f-4bd4-8c83-8a3f36dd9cc7.jpg?guru_height=665&guru_width=1280&guru_size=123726"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/4341390","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["IE00B29SXG58.USD","LU2153592121.USD","LU0605514214.HKD","LU1934453819.USD","LU1146622755.USD","LU1720050803.USD","BK0251","LU0327786744.USD","LU1997245094.SGD","IE0031814852.USD","IE0005HP3H50.USD","LU0572944931.SGD","LU0594300419.USD","LU1580142542.USD","SGXZ81163826.USD","LU1023057109.AUD","LU0405327494.USD","LU0823426308.USD","SGXZ49509284.SGD","LU1997245177.USD","LU1734074674.USD","LU1979443071.USD","LU2213484517.USD","IE0008368742.USD","LU0405327148.USD","LU0359201612.USD","LU0594300179.USD","LU0823426480.USD","LU2153591404.USD","LU0650527681.SGD","LU1655091616.SGD","LU2348773727.SGD","LU2348774022.SGD","LU0084288322.USD","LU2488822045.USD","300760","IE00B031HY20.USD","IE00B031J352.USD","LU1781817850.SGD","LU0359202008.SGD","LU1820825898.SGD","LU1794554557.SGD","LU2424517915.HKD","LU2148510915.USD","LU1064130708.USD","LU1064131003.USD","LU1688375341.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625654936","title":"迈瑞医疗(300760)披露控股股东部分股份质押公告,4月7日股价下跌0.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2625654936","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625654936?lang=zh_cn&edition=full","pubTime":"2026-04-07 17:13","pubTimestamp":1775553203,"startTime":"0","endTime":"0","summary":"截至2026年4月7日收盘,迈瑞医疗报收于157.76元,较前一交易日下跌0.4%,最新总市值为1912.75亿元。公司于近日披露《关于控股股东部分股份质押的公告》。本次合计质押11,800,000股,占公司总股本的0.97%,其中3,600,000股为补充质押,8,200,000股用于其他用途,质权人为招商银行股份有限公司纽约分行。本次质押后,Magnifice累计质押股份占其所持股份比例为18.82%,占公司总股本比例为4.61%。上述质押股份不存在冻结、拍卖或设定信托情况,目前不存在平仓风险。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040700024073.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1934453819.USD","LU0359202008.SGD","IE0031814852.USD","LU1794554557.SGD","LU0405327148.USD","LU2424517915.HKD","LU2488822045.USD","LU2153592121.USD","LU2213484517.USD","LU0650527681.SGD","SGXZ81163826.USD","LU1781817850.SGD","LU0594300419.USD","SGXZ49509284.SGD","LU0572944931.SGD","LU0084288322.USD","IE0005HP3H50.USD","LU1820825898.SGD","LU1580142542.USD","LU2348774022.SGD","LU1146622755.USD","LU1979443071.USD","BK0251","IE00B031J352.USD","LU1720050803.USD","LU0823426308.USD","LU1688375341.USD","LU1997245094.SGD","300760","LU0405327494.USD","LU1997245177.USD","LU0359201612.USD","LU1023057109.AUD","LU0594300179.USD","LU0605514214.HKD","LU1734074674.USD","LU2148510915.USD","LU2348773727.SGD","IE00B031HY20.USD","LU1064131003.USD","IE0008368742.USD","LU1655091616.SGD","LU0823426480.USD","LU2153591404.USD","IE00B29SXG58.USD","LU0327786744.USD","LU1064130708.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625935840","title":"近300家公司获机构密集调研,迈瑞医疗最受关注","url":"https://stock-news.laohu8.com/highlight/detail?id=2625935840","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625935840?lang=zh_cn&edition=full","pubTime":"2026-04-07 16:27","pubTimestamp":1775550440,"startTime":"0","endTime":"0","summary":"从接待机构数量来看,迈瑞医疗以一周接待357家机构的绝对优势位居榜首,成为上周最受关注的公司。2025年,迈瑞医疗营收332.82亿元,同比下滑9.38%;归母净利润84.51亿元,同比下滑28.01%。谈及港股IPO,公司表示,H股上市事项目前正在监管审核中。东鹏饮料以326家机构的接待量紧随其后。金盘科技吸引了279家机构参与特定对象调研,位列上周第三。圣邦股份则吸引了200家机构参与路演活动。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2026040700022428.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1023057109.AUD","LU2153592121.USD","IE0008368742.USD","LU1146622755.USD","LU2153591404.USD","IE00B031HY20.USD","LU0823426308.USD","LU0823426480.USD","LU1820825898.SGD","LU1979443071.USD","LU2488822045.USD","BK0251","SGXZ81163826.USD","LU0572944931.SGD","LU1688375341.USD","LU1734074674.USD","LU2213484517.USD","LU0359201612.USD","LU0405327494.USD","LU1655091616.SGD","LU2148510915.USD","LU1720050803.USD","LU1997245177.USD","LU0594300179.USD","LU1580142542.USD","SGXZ49509284.SGD","IE00B031J352.USD","LU1794554557.SGD","LU0359202008.SGD","LU0084288322.USD","IE0005HP3H50.USD","LU1064131003.USD","LU2424517915.HKD","LU1064130708.USD","LU0327786744.USD","LU0405327148.USD","LU0650527681.SGD","IE0031814852.USD","LU1781817850.SGD","LU2348774022.SGD","IE00B29SXG58.USD","LU1997245094.SGD","LU0605514214.HKD","LU2348773727.SGD","300760","LU0594300419.USD","LU1934453819.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624650921","title":"迈瑞医疗:4月2日高管李朝阳、赵云增持股份合计1.5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2624650921","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624650921?lang=zh_cn&edition=full","pubTime":"2026-04-03 21:01","pubTimestamp":1775221301,"startTime":"0","endTime":"0","summary":"证券之星消息,根据4月3日市场公开信息、上市公司公告及交易所披露数据整理,迈瑞医疗最新董监高及相关人员股份变动情况:2026年4月2日公司高管李朝阳、高管赵云共增持公司股份1.5万股,占公司总股本为0.0012%。迈瑞医疗近半年内的董监高及核心技术人员增减持详情如下:迈瑞医疗的高管列表及最新持股情况如下:融资融券数据显示该股近5日融资净流入1.12亿,融资余额增加;融券净流入1.08万,融券余额增加。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040300041962.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1781817850.SGD","LU0594300179.USD","LU0084288322.USD","LU2153591404.USD","LU2424517915.HKD","LU0823426480.USD","LU2488822045.USD","LU0327786744.USD","LU0594300419.USD","LU1023057109.AUD","IE00B031HY20.USD","LU0823426308.USD","SGXZ49509284.SGD","LU0359202008.SGD","LU0605514214.HKD","LU1997245094.SGD","LU1064131003.USD","BK0251","LU1655091616.SGD","LU2153592121.USD","LU1146622755.USD","LU2213484517.USD","LU2348773727.SGD","IE0008368742.USD","LU0359201612.USD","IE00B29SXG58.USD","LU0650527681.SGD","SGXZ81163826.USD","LU1934453819.USD","LU1979443071.USD","IE0031814852.USD","LU1794554557.SGD","IE0005HP3H50.USD","LU0405327494.USD","LU2148510915.USD","LU1734074674.USD","LU1688375341.USD","LU1064130708.USD","LU1720050803.USD","LU1820825898.SGD","300760","LU2348774022.SGD","LU1580142542.USD","LU0405327148.USD","LU1997245177.USD","LU0572944931.SGD","IE00B031J352.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624018835","title":"迈瑞医疗:数智化方案为客户带来全方位的临床和管理价值","url":"https://stock-news.laohu8.com/highlight/detail?id=2624018835","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624018835?lang=zh_cn&edition=full","pubTime":"2026-04-02 20:48","pubTimestamp":1775134094,"startTime":"0","endTime":"0","summary":"全球医疗机构都在迫切追求提质增效、控费降本,医疗不可能三角的矛盾日益凸显,而迈瑞打造的以“设备+IT+AI”的数智化方案正是解决医疗机构困扰的最优解,我们的数智化方案能够为客户带来全方位的临床和管理价值。对迈瑞而言,数智化转型除了能带来一部分以软件和服务收费为主的额外流水型收入以外,更重要的是为我们的设备业务构筑更加难以被撼动的护城河,并显著提升客户粘性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040200039374.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU0405327148.USD","IE00B29SXG58.USD","LU1979443071.USD","LU0084288322.USD","LU1794554557.SGD","BK0251","LU0605514214.HKD","LU1064130708.USD","LU1580142542.USD","LU2488822045.USD","LU1688375341.USD","LU1781817850.SGD","IE0031814852.USD","LU0594300419.USD","LU1655091616.SGD","LU1023057109.AUD","LU2153592121.USD","LU0359201612.USD","LU1934453819.USD","LU0594300179.USD","IE00B031J352.USD","LU2153591404.USD","LU1734074674.USD","LU2424517915.HKD","LU2348774022.SGD","LU0359202008.SGD","LU1997245177.USD","LU2348773727.SGD","LU1064131003.USD","LU1997245094.SGD","LU1720050803.USD","IE0008368742.USD","LU2213484517.USD","LU0823426308.USD","LU1146622755.USD","300760","SGXZ81163826.USD","LU0823426480.USD","LU2148510915.USD","LU1820825898.SGD","LU0650527681.SGD","IE0005HP3H50.USD","LU0572944931.SGD","SGXZ49509284.SGD","LU0405327494.USD","LU0327786744.USD","IE00B031HY20.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624516035","title":"迈瑞医疗:3月31日郭艳美、李朝阳增持股份合计2.47万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2624516035","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624516035?lang=zh_cn&edition=full","pubTime":"2026-04-01 21:01","pubTimestamp":1775048507,"startTime":"0","endTime":"0","summary":"证券之星消息,根据4月1日市场公开信息、上市公司公告及交易所披露数据整理,迈瑞医疗最新董监高及相关人员股份变动情况:2026年3月31日公司董事,高管郭艳美、高管李朝阳共增持公司股份2.47万股,占公司总股本为0.002%。迈瑞医疗近半年内的董监高及核心技术人员增减持详情如下:迈瑞医疗的高管列表及最新持股情况如下:融资融券数据显示该股近5日融资净流入3642.43万,融资余额增加;融券净流入1.51万,融券余额增加。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040100041254.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SGXZ81163826.USD","LU1146622755.USD","LU1734074674.USD","LU1064130708.USD","LU0084288322.USD","BK0251","IE0005HP3H50.USD","LU0650527681.SGD","LU1997245177.USD","LU0405327494.USD","LU2348774022.SGD","SGXZ49509284.SGD","LU1064131003.USD","LU0405327148.USD","LU0605514214.HKD","LU1781817850.SGD","IE0008368742.USD","IE00B031J352.USD","IE00B29SXG58.USD","LU0823426308.USD","LU0594300419.USD","300760","LU2153591404.USD","LU2153592121.USD","IE0031814852.USD","LU1688375341.USD","LU2488822045.USD","LU1655091616.SGD","LU1023057109.AUD","LU1580142542.USD","LU1820825898.SGD","LU2424517915.HKD","LU0572944931.SGD","LU0823426480.USD","LU0359202008.SGD","LU1979443071.USD","LU1794554557.SGD","LU2213484517.USD","IE00B031HY20.USD","LU2348773727.SGD","LU0327786744.USD","LU0359201612.USD","LU0594300179.USD","LU2148510915.USD","LU1720050803.USD","LU1997245094.SGD","LU1934453819.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624267593","title":"迈瑞医疗:公司H股上市事项目前正在监管审核中","url":"https://stock-news.laohu8.com/highlight/detail?id=2624267593","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624267593?lang=zh_cn&edition=full","pubTime":"2026-04-01 15:57","pubTimestamp":1775030228,"startTime":"0","endTime":"0","summary":"证券之星消息,迈瑞医疗04月01日在投资者关系平台上答复投资者关心的问题。本次发行并上市仍需取得中国证券监督管理委员会、香港证监会和香港联交所等相关政府机关、监管机构、证券交易所的批准、核准或备案,一切关于上市的进展信息,请以公司后续发布的公告为准。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040100027617.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","LU0594300179.USD","IE00B031J352.USD","LU1580142542.USD","LU2424517915.HKD","IE00B031HY20.USD","LU1820825898.SGD","LU1023057109.AUD","SGXZ81163826.USD","LU1934453819.USD","LU1146622755.USD","LU2213484517.USD","LU1064131003.USD","LU0359202008.SGD","LU0572944931.SGD","LU0823426480.USD","LU0405327148.USD","LU2153592121.USD","LU0405327494.USD","LU2148510915.USD","300760","LU1720050803.USD","LU2348773727.SGD","LU0605514214.HKD","IE00B29SXG58.USD","LU1688375341.USD","LU0594300419.USD","LU0327786744.USD","LU1794554557.SGD","LU1997245094.SGD","LU2488822045.USD","LU2153591404.USD","IE0008368742.USD","LU1997245177.USD","LU1655091616.SGD","LU1979443071.USD","LU1734074674.USD","LU1781817850.SGD","SGXZ49509284.SGD","LU0084288322.USD","LU0823426308.USD","LU1064130708.USD","IE0031814852.USD","IE0005HP3H50.USD","LU2348774022.SGD","LU0359201612.USD","LU0650527681.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624265593","title":"迈瑞医疗:2025年净利润率下降了6.57个百分点","url":"https://stock-news.laohu8.com/highlight/detail?id=2624265593","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624265593?lang=zh_cn&edition=full","pubTime":"2026-04-01 15:57","pubTimestamp":1775030226,"startTime":"0","endTime":"0","summary":"证券之星消息,迈瑞医疗04月01日在投资者关系平台上答复投资者关心的问题。2025年净利润率下降了6.57个百分点,其中最核心的影响因素是毛利率下降了2.80个百分点,这背后是因为国内业务三大产线毛利率均因产品价格下降而出现了不同程度的下降,但国际业务毛利率维持平稳。国内产品价格下降主要受医院采购预算缩减、竞争环境激烈、医保持续深化改革等因素影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040100027608.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300760"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624567298","title":"中银证券:给予迈瑞医疗买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2624567298","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624567298?lang=zh_cn&edition=full","pubTime":"2026-04-01 14:55","pubTimestamp":1775026514,"startTime":"0","endTime":"0","summary":"中银国际证券股份有限公司刘恩阳,苏雪儿近期对迈瑞医疗进行研究并发布了研究报告《业绩短期承压,新兴业务表现亮眼》,给予迈瑞医疗买入评级。公司海外业务稳步推进,国内业务筑底回升,新业务快速发展叠加数智化放量,公司业绩有望恢复快速增长,维持买入评级。最新盈利预测明细如下:该股最近90天内共有7家机构给出评级,买入评级5家,增持评级2家;过去90天内机构目标均价为284.7。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040100021912.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601696","300760"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623734527","title":"迈瑞医疗2025年营收同比下降9.4%,净利润降30.3%,新兴业务增长30% | 财报见闻","url":"https://stock-news.laohu8.com/highlight/detail?id=2623734527","media":"华尔街见闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623734527?lang=zh_cn&edition=full","pubTime":"2026-03-30 21:50","pubTimestamp":1774878643,"startTime":"0","endTime":"0","summary":"迈瑞医疗2025年营收332.82亿,同比下降9.38%,净利润81.36亿,下降30.28%,国内政策压力导致医院采购预算缩减是主因。国际收入首超国内占比升至53%,欧洲劲增17%。微创外科等新兴业务增长38.85%。管理层预期2026年国内业务重回正增长。","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":"6e7a4338b1034ad785d5025385d8625c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3768782","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["300760"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623534326","title":"迈瑞医疗2025年营收332.82亿,国际业务占比提升至53%,研发投入39.29亿,公司累计专利数量超12000件","url":"https://stock-news.laohu8.com/highlight/detail?id=2623534326","media":"新浪证券","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623534326?lang=zh_cn&edition=full","pubTime":"2026-03-30 21:27","pubTimestamp":1774877220,"startTime":"0","endTime":"0","summary":" 3月30日,迈瑞医疗发布2025年年度报告。报告期内,公司实现营业收入332.82亿元,实现净利润84.51亿元。 报告期内,国际业务实现营业收入176.50亿元,同比增长7.40%,占公司总营收的比例达到53%。 2025年,迈瑞医疗全年研发投入达到39.29亿元,占总营业收入的11.80%,占比再度提升。2025年度公司累计现金分红总额将达到53.10亿元,现金分红比例为65.27%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/marketresearch/2026-03-30/doc-inhsuqus9566776.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["300760"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623368508","title":"股市必读:迈瑞医疗(300760)3月27日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2623368508","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623368508?lang=zh_cn&edition=full","pubTime":"2026-03-30 04:30","pubTimestamp":1774816230,"startTime":"0","endTime":"0","summary":"截至2026年3月27日收盘,迈瑞医疗报收于169.6元,上涨3.23%,换手率0.65%,成交量7.9万手,成交额13.27亿元。董秘最新回复投资者: 一季度马上就过去了,咱们证券部门都做了哪些工作。公司将于2026年3月31日发布2025年年度报告,敬请关注,谢谢。其中,进口品牌仍占市场主要份额的IVD 市场对公司来说机遇无疑最大。当日关注点来自交易信息汇总:3月27日主力资金净流入421.71万元,显示主力对迈瑞医疗股票短期态度偏积极。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026033000000961.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU0327786744.USD","LU0594300179.USD","LU0084288322.USD","LU1997245177.USD","LU0572944931.SGD","LU1820825898.SGD","LU0594300419.USD","LU2148510915.USD","LU2348774022.SGD","LU0605514214.HKD","LU2213484517.USD","LU1794554557.SGD","IE0008368742.USD","LU1997245094.SGD","LU2424517915.HKD","LU1023057109.AUD","LU0359201612.USD","LU1734074674.USD","IE00B031HY20.USD","SGXZ81163826.USD","LU1655091616.SGD","LU1781817850.SGD","LU0405327148.USD","300760","BK0251","IE00B031J352.USD","LU0405327494.USD","LU2348773727.SGD","LU0359202008.SGD","LU0823426480.USD","LU1720050803.USD","LU2488822045.USD","LU0650527681.SGD","SGXZ49509284.SGD","LU2153591404.USD","LU2153592121.USD","LU1688375341.USD","LU1064131003.USD","LU1146622755.USD","LU1064130708.USD","LU1580142542.USD","LU1979443071.USD","IE0005HP3H50.USD","IE00B29SXG58.USD","LU0823426308.USD","IE0031814852.USD","LU1934453819.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622863973","title":"迈瑞医疗:国内业务2026年全年有望实现正增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2622863973","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622863973?lang=zh_cn&edition=full","pubTime":"2026-03-28 17:33","pubTimestamp":1774690391,"startTime":"0","endTime":"0","summary":"长期来看,除了 IVD 仍有巨大的市占率提升空间以外,迈瑞的微创外科、微创介入等耗材业务目前的占有率甚至可以忽略不计,而这两块业务的合计市场容量大于IVD,并且随着手术量和手术渗透率的增长,行业仍有很大的成长空间。因此综合来看,我们预计国内业务2026年全年有望实现正增长,其中IVD将引领三大产线的增长,新兴业务将实现高速增长。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032800022113.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1146622755.USD","LU2213484517.USD","LU1979443071.USD","LU0594300419.USD","LU1688375341.USD","LU0605514214.HKD","LU1734074674.USD","LU1820825898.SGD","LU1580142542.USD","LU2348774022.SGD","LU1064131003.USD","IE0005HP3H50.USD","LU0359202008.SGD","LU1064130708.USD","LU1023057109.AUD","SGXZ81163826.USD","LU0405327494.USD","IE0031814852.USD","LU0405327148.USD","SGXZ49509284.SGD","LU2148510915.USD","LU1720050803.USD","LU0823426480.USD","LU0327786744.USD","LU2424517915.HKD","LU1997245177.USD","IE00B29SXG58.USD","LU0572944931.SGD","IE00B031J352.USD","LU2153592121.USD","LU0823426308.USD","LU2348773727.SGD","LU0594300179.USD","300760","LU1997245094.SGD","LU2488822045.USD","IE00B031HY20.USD","LU1794554557.SGD","LU0650527681.SGD","LU1934453819.USD","LU0359201612.USD","LU2153591404.USD","LU1781817850.SGD","LU0084288322.USD","LU1655091616.SGD","BK0251","IE0008368742.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622407697","title":"迈瑞医疗:基于可穿戴传感器以及AI诊断和预警算法的慢病管理新方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2622407697","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622407697?lang=zh_cn&edition=full","pubTime":"2026-03-25 20:52","pubTimestamp":1774443141,"startTime":"0","endTime":"0","summary":"我们在研的基于可穿戴传感器以及AI诊断和预警算法的慢病管理新方案,旨在实现对患者生命体征的持续、无感监测,弥补传统诊疗中“数据真空”的短板,并基于可穿戴设备获得的高质量数据,融合其他的多模态临床数据,通过AI算法实现高效诊断、风险分析和预警。该方案的核心优势在于,将基于院内的迈瑞的完整监护解决方案,进一步延伸到基层和家庭,构筑起围绕病人旅程的完整解决方案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032500041822.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","LU0594300179.USD","IE00B031J352.USD","LU1580142542.USD","LU2424517915.HKD","IE00B031HY20.USD","LU1820825898.SGD","LU1023057109.AUD","SGXZ81163826.USD","LU1934453819.USD","LU1146622755.USD","LU2213484517.USD","LU1064131003.USD","LU0359202008.SGD","LU0572944931.SGD","LU0823426480.USD","LU0405327148.USD","LU2153592121.USD","LU0405327494.USD","LU2148510915.USD","300760","LU1720050803.USD","LU2348773727.SGD","LU0605514214.HKD","IE00B29SXG58.USD","LU1688375341.USD","LU0594300419.USD","LU0327786744.USD","LU1794554557.SGD","LU1997245094.SGD","LU2488822045.USD","LU2153591404.USD","IE0008368742.USD","LU1997245177.USD","LU1655091616.SGD","LU1979443071.USD","LU1734074674.USD","LU1781817850.SGD","SGXZ49509284.SGD","LU0084288322.USD","LU0823426308.USD","LU1064130708.USD","IE0031814852.USD","IE0005HP3H50.USD","LU2348774022.SGD","LU0359201612.USD","LU0650527681.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621632190","title":"迈瑞医疗:IVD核心业务国内市场占有率三年内从10%提升至20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2621632190","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621632190?lang=zh_cn&edition=full","pubTime":"2026-03-24 18:03","pubTimestamp":1774346595,"startTime":"0","endTime":"0","summary":"证券之星消息,迈瑞医疗03月24日在投资者关系平台上答复投资者关心的问题。公司已经提出了明确的阶段性目标,IVD的核心业务化学发光、生化、凝血在国内的市场占有率要从当前的10%,在三年之内提升至20%,实现这一目标的核心途径是双大突破。同时,进口品牌在化学发光领域的占有率仍超过60%,凝血的这一比例还会更高,并且进口品牌的份额高度集中在大样本量医院,对迈瑞而言替代的空间巨大。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400032226.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2424517915.HKD","IE00B29SXG58.USD","LU1146622755.USD","LU2213484517.USD","LU1997245177.USD","LU0359202008.SGD","IE00B031HY20.USD","LU1064130708.USD","IE00B031J352.USD","SGXZ81163826.USD","LU0823426480.USD","LU0405327148.USD","LU0084288322.USD","IE0008368742.USD","LU1979443071.USD","LU1734074674.USD","LU1794554557.SGD","LU2348773727.SGD","LU2148510915.USD","LU1580142542.USD","LU1781817850.SGD","LU1934453819.USD","LU0823426308.USD","LU0572944931.SGD","LU1997245094.SGD","LU1064131003.USD","LU2153592121.USD","LU0605514214.HKD","LU1820825898.SGD","SGXZ49509284.SGD","LU0359201612.USD","LU0594300179.USD","BK0251","LU2488822045.USD","LU0650527681.SGD","LU0594300419.USD","LU1720050803.USD","LU2153591404.USD","LU1023057109.AUD","LU1688375341.USD","IE0031814852.USD","LU2348774022.SGD","LU1655091616.SGD","LU0327786744.USD","300760","IE0005HP3H50.USD","LU0405327494.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621063437","title":"迈瑞医疗:与美国Teratech的专利诉讼仍处于早期阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2621063437","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621063437?lang=zh_cn&edition=full","pubTime":"2026-03-24 18:00","pubTimestamp":1774346426,"startTime":"0","endTime":"0","summary":"与美国Teratech的专利诉讼,公司已经聘请有丰富诉讼经验的美国律师团队,并成立专项小组进行案件处理。目前,案件仍处于早期阶段,公司已经在2025年12月发起驳回起诉动议,预计2026年法院将会针对该动议做出裁决。在案件处理的过程中,迈瑞公司将按照国际通行的知识产权规则并结合美国专利诉讼要求,分别从专利不侵权、专利无效等相关方面处理纠纷,确保公司美国产品销售不受影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400031773.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","LU0594300179.USD","LU1997245094.SGD","LU1064131003.USD","LU0605514214.HKD","SGXZ49509284.SGD","LU1688375341.USD","LU0405327148.USD","LU0359201612.USD","LU2153592121.USD","SGXZ81163826.USD","IE00B29SXG58.USD","LU1064130708.USD","LU1734074674.USD","LU2348773727.SGD","LU1146622755.USD","LU2213484517.USD","IE00B031HY20.USD","IE00B031J352.USD","LU0405327494.USD","LU1580142542.USD","LU1655091616.SGD","LU1781817850.SGD","LU2153591404.USD","LU0084288322.USD","IE0005HP3H50.USD","IE0008368742.USD","LU1997245177.USD","LU2148510915.USD","LU0359202008.SGD","LU2348774022.SGD","LU1720050803.USD","LU2488822045.USD","LU1794554557.SGD","LU1934453819.USD","LU1023057109.AUD","LU1979443071.USD","LU0650527681.SGD","LU0823426308.USD","LU1820825898.SGD","LU2424517915.HKD","300760","LU0594300419.USD","LU0327786744.USD","LU0572944931.SGD","LU0823426480.USD","IE0031814852.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621117063","title":"迈瑞医疗:高管在年报披露前15日内不得买卖本公司股票","url":"https://stock-news.laohu8.com/highlight/detail?id=2621117063","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621117063?lang=zh_cn&edition=full","pubTime":"2026-03-24 18:00","pubTimestamp":1774346422,"startTime":"0","endTime":"0","summary":"证券之星消息,迈瑞医疗03月24日在投资者关系平台上答复投资者关心的问题。我要问的是贵司高管李朝阳在年报披露日前30日内增持是否违规?若违规贵司将如何惩罚或约束高管类似行为?","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400031768.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU0823426308.USD","LU1064131003.USD","LU2348773727.SGD","LU0605514214.HKD","LU1734074674.USD","LU2153591404.USD","SGXZ49509284.SGD","LU1720050803.USD","LU0084288322.USD","LU0572944931.SGD","LU2348774022.SGD","LU2488822045.USD","LU2148510915.USD","LU1820825898.SGD","LU1979443071.USD","LU1794554557.SGD","LU1580142542.USD","LU1146622755.USD","LU2153592121.USD","SGXZ81163826.USD","LU0327786744.USD","LU0359201612.USD","300760","IE00B031HY20.USD","IE0031814852.USD","LU0405327494.USD","LU0823426480.USD","LU1781817850.SGD","LU1997245094.SGD","LU1655091616.SGD","IE00B031J352.USD","LU0650527681.SGD","LU0594300179.USD","LU2213484517.USD","LU1023057109.AUD","IE0008368742.USD","IE00B29SXG58.USD","LU1688375341.USD","LU1934453819.USD","LU1997245177.USD","LU1064130708.USD","LU0594300419.USD","LU0405327148.USD","BK0251","IE0005HP3H50.USD","LU2424517915.HKD","LU0359202008.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621063538","title":"迈瑞医疗:预计国内业务2026年全年有望实现正增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2621063538","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621063538?lang=zh_cn&edition=full","pubTime":"2026-03-24 17:57","pubTimestamp":1774346227,"startTime":"0","endTime":"0","summary":"长期来看,除了 IVD 仍有巨大的市占率提升空间以外,迈瑞的微创外科、微创介入等耗材业务目前的占有率甚至可以忽略不计,而这两块业务的合计市场容量大于 IVD,并且随着手术量和手术渗透率的增长,行业仍有很大的成长空间。因此综合来看,我们预计国内业务2026年全年有望实现正增长,其中IVD 将引领三大产线的增长,新兴业务将实现高速增长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400031212.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","LU0594300179.USD","IE00B031J352.USD","LU1580142542.USD","LU2424517915.HKD","IE00B031HY20.USD","LU1820825898.SGD","LU1023057109.AUD","SGXZ81163826.USD","LU1934453819.USD","LU1146622755.USD","LU2213484517.USD","LU1064131003.USD","LU0359202008.SGD","LU0572944931.SGD","LU0823426480.USD","LU0405327148.USD","LU2153592121.USD","LU0405327494.USD","LU2148510915.USD","300760","LU1720050803.USD","LU2348773727.SGD","LU0605514214.HKD","IE00B29SXG58.USD","LU1688375341.USD","LU0594300419.USD","LU0327786744.USD","LU1794554557.SGD","LU1997245094.SGD","LU2488822045.USD","LU2153591404.USD","IE0008368742.USD","LU1997245177.USD","LU1655091616.SGD","LU1979443071.USD","LU1734074674.USD","LU1781817850.SGD","SGXZ49509284.SGD","LU0084288322.USD","LU0823426308.USD","LU1064130708.USD","IE0031814852.USD","IE0005HP3H50.USD","LU2348774022.SGD","LU0359201612.USD","LU0650527681.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621006355","title":"迈瑞医疗:2025年前三季度MT 8000全实验室智能化流水线销售超过20套","url":"https://stock-news.laohu8.com/highlight/detail?id=2621006355","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621006355?lang=zh_cn&edition=full","pubTime":"2026-03-24 17:54","pubTimestamp":1774346051,"startTime":"0","endTime":"0","summary":"证券之星消息,迈瑞医疗03月24日在投资者关系平台上答复投资者关心的问题。2025年前三季度,公司在国际市场实现MT 8000全实验室智能化流水线销售超过20套,已提前完成全年任务。随着海外中大样本量客户突破持续MT8000流水线销售放量,国际体外诊断产线未来有望继续维持快速增长的趋势。从目前定位的2200 多家双大客户中,截至2025年三季度末,我们已经突破了70家。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400030655.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300760","IE00B031J352.USD","LU1997245177.USD","LU0327786744.USD","SGXZ49509284.SGD","LU1820825898.SGD","LU0605514214.HKD","LU1023057109.AUD","LU0405327148.USD","LU1064130708.USD","LU1720050803.USD","LU1979443071.USD","LU2213484517.USD","IE00B29SXG58.USD","LU1655091616.SGD","LU1146622755.USD","LU1781817850.SGD","LU2424517915.HKD","LU0823426480.USD","LU0359201612.USD","LU2148510915.USD","LU0572944931.SGD","LU0084288322.USD","LU0405327494.USD","LU1997245094.SGD","IE0031814852.USD","LU2488822045.USD","IE0005HP3H50.USD","LU1580142542.USD","LU2153592121.USD","SGXZ81163826.USD","LU0650527681.SGD","LU2348773727.SGD","LU2348774022.SGD","LU0594300179.USD","LU1064131003.USD","LU1734074674.USD","LU1934453819.USD","LU0359202008.SGD","LU1688375341.USD","LU1794554557.SGD","LU0594300419.USD","LU0823426308.USD","IE0008368742.USD","IE00B031HY20.USD","LU2153591404.USD","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620736227","title":"迈瑞医疗:微创外科、心血管是公司定义的高潜力业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2620736227","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620736227?lang=zh_cn&edition=full","pubTime":"2026-03-20 20:51","pubTimestamp":1774011106,"startTime":"0","endTime":"0","summary":"微创外科、心血管是公司定义的高潜力业务,连同动物医疗,这三个业务2024年的体量占公司总收入的比重已经超过了10%,并且增速都在 25%以上,2025 年上半年整体规模超过人民币26亿元,收入贡献比例突破15%,预计未来还会延续高速增长的趋势,给公司的业绩带来积极显著的贡献。公司通过微创外科业务探索手术机器人业务。2025年是迈瑞微创外科核心业务超声刀、腔镜吻合器等高值耗材在国内放量的元年。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032000040361.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1934453819.USD","LU0359202008.SGD","IE0031814852.USD","LU1794554557.SGD","LU0405327148.USD","LU2424517915.HKD","LU2488822045.USD","LU2153592121.USD","LU2213484517.USD","LU0650527681.SGD","SGXZ81163826.USD","LU1781817850.SGD","LU0594300419.USD","SGXZ49509284.SGD","LU0572944931.SGD","LU0084288322.USD","IE0005HP3H50.USD","LU1820825898.SGD","LU1580142542.USD","LU2348774022.SGD","LU1146622755.USD","LU1979443071.USD","BK0251","IE00B031J352.USD","LU1720050803.USD","LU0823426308.USD","LU1688375341.USD","LU1997245094.SGD","300760","LU0405327494.USD","LU1997245177.USD","LU0359201612.USD","LU1023057109.AUD","LU0594300179.USD","LU0605514214.HKD","LU1734074674.USD","LU2148510915.USD","LU2348773727.SGD","IE00B031HY20.USD","LU1064131003.USD","IE0008368742.USD","LU1655091616.SGD","LU0823426480.USD","LU2153591404.USD","IE00B29SXG58.USD","LU0327786744.USD","LU1064130708.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1775752664509,"stockEarnings":[{"period":"1week","weight":-0.0376},{"period":"1month","weight":-0.1333},{"period":"3month","weight":-0.2326},{"period":"6month","weight":-0.3499},{"period":"1year","weight":-0.2536},{"period":"ytd","weight":-0.1793}],"compareEarnings":[{"period":"1week","weight":0.012},{"period":"1month","weight":-0.0381},{"period":"3month","weight":-0.0374},{"period":"6month","weight":0.0177},{"period":"1year","weight":0.2446},{"period":"ytd","weight":-0.0007}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"深圳迈瑞生物医疗电子股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"152491人(较上一季度增加12.79%)","perCapita":"7944股","listingDate":"2018-10-16","address":"广东省深圳市南山区高新技术产业园区科技南十二路迈瑞大厦1-4层","registeredCapital":"121244万元","survey":" 深圳迈瑞生物医疗电子股份有限公司的主营业务是医疗器械的研发、制造、营销及服务。公司的主要产品是体外诊断类产品、生命信息与支持类产品、医学影像类产品、新兴业务类产品、其他业务。2025年,公司自主研发的发明专利“试剂、分析血小板的方法及血液细胞分析仪”荣获第十届广东专利奖金奖。","listedPrice":48.8},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"迈瑞医疗(300760)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供迈瑞医疗(300760)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"迈瑞医疗,300760,迈瑞医疗股票,迈瑞医疗股票老虎,迈瑞医疗股票老虎国际,迈瑞医疗行情,迈瑞医疗股票行情,迈瑞医疗股价,迈瑞医疗股市,迈瑞医疗股票价格,迈瑞医疗股票交易,迈瑞医疗股票购买,迈瑞医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"迈瑞医疗(300760)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供迈瑞医疗(300760)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}